title: Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
authors.affiliation: University of Pittsburgh Medical Center Shadyside Family Medicine Residency Program, Pittsburgh, PA, USA.
authors.forename: Barry
authors.initials: B
authors.lastname: Coutinho
authors.affiliation: University of Pittsburgh Medical Center Shadyside Family Medicine Residency Program, Pittsburgh, PA, USA.
authors.forename: Ramakrishna
authors.initials: R
authors.lastname: Prasad
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004338:Drug Combinations; D016527:Drug Costs; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine